Regorafenib in metastatic colorectal cancer: An exploratory biomarker trial.

被引：0
|
作者：
Salem, Mohamed E.
Petricoin, Emanuel
Wellstein, Anton
Pierobon, Mariaelena
Wang, Hongkun
Mikhail, Sameh
Hartley, Marion L.
Smaglo, Brandon George
Lou, Emil
Alistar, Angela Tatiana
Dorsch-Vogel, Karen
Pishvaian, Michael J.
He, Aiwu Ruth
Kim, Alexander Y.
Shivapurkar, Narayan
Reddy, Sandeep K.
Marshall, John
机构：
[1] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[2] George Mason Univ, Manassas, VA USA
[3] Ohio State Univ, James Canc Hosp, Ctr Comprehens Canc, Solove Res Inst, Columbus, OH 43210 USA
[4] Univ Minnesota, Hopkins, MN USA
[5] Wake Forest Sch Med, Winston Salem, NC USA
[6] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[7] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Med & Oncol, Washington, DC USA
[8] Georgetown Univ, Lombardi Comprehens Canc Ctr, Innovat Ctr Biomed Informat, Washington, DC USA
[9] Medstar Georgetown Univ Hosp, Intervent Radiol, Washington, DC USA
[10] Caris Life Sci, Phoenix, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.tps773
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS773
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Total lesion glycolysis (TLG) as an imaging biomarker in metastatic colorectal cancer patients treated with regorafenib
    Lim, Yoojoo
    Bang, Ji-In
    Han, Sae-Won
    Paeng, Jin Chul
    Lee, Kyung-Hun
    Kim, Jee Hyun
    Kang, Gyeong Hoon
    Jeong, Seung-Yong
    Park, Kyu Joo
    Kim, Tae-You
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (05) : 757 - 764
  • [22] Effects of regorafenib therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial.
    Qin, Shukui
    Kim, Tae Won
    Yau, Thomas Cheung
    Ma, Brigette
    Pan, Hongming
    Xu, Jian-Ming
    Bai, Yuxian
    Wang, Liwei
    Yeh, Kun-Huei
    Bi, Feng
    Cheng, Ying
    Tuan Anh Le
    Lin, Jen-Kou
    Liu, Tianshu
    Dong, Ma
    Kappeler, Christian
    Chang, Jane
    Xu, Rui-hua
    Li, Jin
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [23] Exploratory biomarker analyses in phase 1 study of regorafenib, ipilimumab, and nivolumab (RIN) in chemotherapy resistant microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
    Ye, Jian
    Wang, Chongkai
    Egelston, Colt
    Guo, Weihua
    Lee, Peter P.
    Fakih, Marwan
    CANCER RESEARCH, 2023, 83 (07)
  • [24] Drug safety data of Regorafenib in metastatic colorectal cancer
    Dayani, P.
    Ablard, C.
    Pinel, S.
    Demirdjian, S.
    Laghouati, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1313 - 1313
  • [25] Regorafenib in Patients With Relapsed Advanced or Metastatic Colorectal Cancer
    Bekaii-Saab, Tanios S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (09) : 10 - 11
  • [26] Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer
    Alandag, Celal
    Karaman, Elanur
    Yuce, Elif
    ANTI-CANCER DRUGS, 2022, 33 (04) : 389 - 393
  • [27] Regorafenib in antiangiogenic-naive, chemotherapy-refractory advanced colorectal cancer: A phase IIb trial.
    Riechelmann, Rachel Pimenta
    Leite, Luiz Antonio Senna
    Glasberg, Joao
    Bariani, Giovanni Mendonca
    Rivelli, Thomas Giollo
    Nebuloni, Daniela R.
    Puty, Fabiola
    Kappeler, Christian
    Pereira, Kaline M. C.
    Queiroz, Marcelo A.
    Hoff, Paulo Marcelo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [28] FDA Approves Regorafenib (Stivarga) for Metastatic Colorectal Cancer
    不详
    ONCOLOGY-NEW YORK, 2012, 26 (10): : 896 - 896
  • [29] Imaging and clinical correlates with regorafenib in metastatic colorectal cancer
    Khan, Khurum
    Cascinu, Stefano
    Cunningham, David
    Kim, Sun-Young
    Oki, Eiji
    Seery, Tara
    Shen, Lin
    Siena, Salvatore
    Tournigand, Christophe
    Turhal, Nazim Serdar
    Hendlisz, Alain
    CANCER TREATMENT REVIEWS, 2020, 86
  • [30] Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer
    Kawakami, Kazuyoshi
    Wakatsuki, Takeru
    Soejima, Azusa
    Kobayashi, Kazuo
    Yokokawa, Takashi
    Aoyama, Takeshi
    Suzuki, Kenichi
    Suenaga, Mitsukuni
    Yamaguchi, Kensei
    Inoue, Ayaka
    Machida, Yoshiaki
    Hama, Toshihiro
    PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 1745 - 1750
12345